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Diazepam in vitro produced a concentration-dependent increase of membrane fluidity in crude synaptic 
membranes from rat hippocampus, but not cerebellum. Similar effects were obtained with higher 
concentrations of Ro 15-1788 and PK 11195, while zopiclone was completely inactive. In vivo acute 
treatment with diazepam and Ro 15-1788 gave results similar to those in vitro. The specific benzodiazepine 
antagonist also significantly increased membrane fluidity and was not able to reverse diazepam’s effect. 
The data are discussed in terms of a possible role of protein kinase inhibition by the drugs not mediated 
by the ‘central’ or ‘peripheral’ type of benzodiazepine receptors. 
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1. INTRODUCTION 
It was recently reported that occupancy of ben- 
zodiazepine (BDZ) binding sites in cultured C6 
astrocytoma cells by this group of drugs enhanced 
[3H]methyl moiety incorporation into phosphati- 
dylcholine [ 11. Although BDZ-binding sites on 
astrocytoma cells have different properties from 
those in the brain (i.e., peripheral type BDZ recep- 
tors) this was the first biochemical event reported 
as a consequence of receptor occupancy [2]. 
The synthesis and translocation of methylated 
phospholipids were reported to change the number 
of [3H]diazepam-binding sites, unmasking the 
high-affinity component and raising the apparent 
B,,, values for the low-affinity component of 
[3H]GABA receptors [3]. We therefore decided to 
check whether in vivo occupancy of brain BDZ 
receptors by pharmacologically relevant doses of 
diazepam affected membrane fluidity. 
* To whom correspondence should be addressed 
2. MATERIALS AND METHODS 
Male rats (Sprague-Dawley CD-COBS, 200 g, 
Charles River Italy, Calco, Como) were given 
10 mg/kg i.p. of diazepam (Hoffmann-La Roche, 
Basel) or vehicle then 1 min later 30 mg/kg p.o. 
Ro 15-1788 (Hoffmann-La Roche) or vehicle; they 
were killed 15 min after diazepam. Drugs were 
suspended in 0.5% carboxymethylcellulose. 
Synaptosomes were obtained from brain areas as 
in [4]. The P2B fractions (interface between 0.8 
and 1.2 M sucrose) were diluted with 0.05 M 
phosphate buffered-saline (PBS; pH 7.4), cen- 
trifuged at 17000 x g for 10 min and then 
resuspended in PBS using an Ultra-Turrax (TP 
18-10) at medium setting for 20 s to give a final 
protein concentration of about 0.25 mg/ml [5]. 
For in vitro experiments, crude synaptic mem- 
branes were obtained from P2B fractions of un- 
treated rats by resuspension in ice-cold water for 
15 min, homogenization with the Ultra-Turrax for 
30 s, and centrifugation at 8000 x g for 20 min. 
The supernatants and buffy coats were carefully 
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removed, and centrifuged at 48000 x g for 20 min. 
The final pellets were resuspended in PBS as 
described above. 
Membrane microviscosity was determined by the 
fluorescence polarization technique as in [6] using 
1,6_diphenylhexatriene (DPH) (Aldrich) as 
fluorescent probe. Membrane preparations (2 ml) 
were incubated with a final DPH concentration of 
10m6 M for 30 min at 4°C. The fluorescence 
polarization value, P, was determined at 37°C with 
an Elscint MV-1 instrument (Haifa, Israel). 
For in vitro experiments, diazepam and 
Ro 15-1788 were dissolved as their hydrochlorides 
in PBS (pH 7) at a final concentration of 10v4 M. 
PK 11195 (Pharmuka Laboratories, Gennevilliers, 
France) was dissolved in PBS-EtOH (50: 50, v/v) 
at a concentration of 0.1 M. Zopiclone (Rhone- 
Poulenc, Vitry-sur-Seine, France) was dissolved as 
its hydrochloride in PBS (pH 7) or in 
PBS-dimethylformamide (50: 50, v/v) at 10m3 M. 
The in vitro membrane-fluidizing effect of the 
drugs was determined as follows: to 3 ml of DPH- 
labelled membrane preparation 0.050-o. 100 ml 
drug solutions were added to obtain final concen- 
trations ranging from 10m5 to lOpi2 M. The P 
value was first recorded before the addition of the 
drug, then every 2 min until no further membrane 
microviscosity change was detected. The data for 
all the determinations are in relation to this time. 
A blank of the solutions used for dissolving the 
drugs was always run to estimate any change in 
microviscosity due to the solvent effect. The possi- 
ble spectral interaction between DPH and the 
drugs was verified by checking the absence of in- 
terfering absorbances at DPH emission 
wavelength. 
3. RESULTS 
Fig.1 reports the data in vitro after addition of 
10-5-10-10 M diazepam (A) or Ro 15-1788 (B) to 
hippocampal or cerebellum crude synaptic mem- 
branes. The data are expressed as the ratio of the 
membrane microviscosity 20 min after adding the 
drug (i.e., 7D) and the basal value (i.e., qO) vs the 
antilogarithm of drug concentration. At 10m5 M 
diazepam increased the microviscosity by 10% and 
at lo-” M the figure was still -2%. On the other 
hand, this compound had little effect on 
cerebellum crude synaptic membranes. In this case 
256 
bh0 
1.0000- 
1 
0.9 250- 
A 
0.85OOj, 
5 6 
- Log ‘[Dia8zepa9m] 
IO 
1 .o 000, 
5 6 7 8 9 10 
- Log [Ro 15-1’881 
6 
Fig. 1. Dose-response curves of in vitro fluidizing effect 
of diazepam (A) and Ro 15-1788 (B) on hippocampus 
(W) and cerebellum (M) synaptic membranes. 
qo, microviscosity 20 min after addition of the drug; qO, 
basal value. Each point is the mean of 4 different 
experiments. 
at 10e5 M the change amounted only to 3.2%. 
Panel B shows the findings with Ro 15-1788. This 
compound had much less effect than diazepam in 
hippocampus, the maximum effect, at 10m5 M, be- 
ing about 5% of basal value. No effect at all was 
observed with cerebellum synaptosomal mem- 
branes. 
The in vitro effects of two other compounds 
(PK 11195 and zopiclone) were tested at 10m5 M 
on hippocampal crude synaptic membranes. 
PK 11195 gave an ID/lo value of 0.95, thus caus- 
ing 5% fluidization, whereas zopiclone was com- 
pletely ineffective (not reported). 
Table 1 lists the findings in hippocampal synap- 
tosomes after in vivo treatments. Diazepam 
significantly increases membrane fluidity, by 6%. 
This effect appeared to be confined to specific 
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Table 1 
Membrane lipid microviscosity in rat hippocampus 
synaptosomes 
Treatment Microviscosity (P) at 37% 
Vehicle + vehicle 2.7325 + 0.0519 (8) 
Diazepam + vehicle 2.5856 k 0.0036’ (9) 
Vehicle + Ro 15-1788 2.4967 + 0.050Tb (5) 
Diazepam + Ra 15-1788 2.4706 f 0.049gb (6) 
Data are the mean k SE; number of animals in brackets. 
a p < 0.05; b p c 0.01 different from controls; Dunnett’s 
test. F for interaction (ANQVA), not statistically 
significant 
membrane domains, since it was not detected in 
crude PZ fraction or in whole homogenate (not 
shown). 
Diazepam seemed to show regional specificity 
since fluidity was unmodified in synaptosomes 
from cerebehum (controls 2.65 + 0.040 9 vs 
diazepam 2.74 f 0.01). The levels of diazepam 
were 0.45 ~-t 0.1 @g/g in hippocampus and 0.51 + 
0.1 /rg/g in cerebellum. Ro 15-1788 per se in- 
creased membrane fluidity in hippocampal synap- 
tosomes and the two drugs showed no statistically 
significant interaction when administered together. 
4. DISCUSSION 
This paper reports for the first time the in vivo 
modmation of membrane fi uidity after a single ac- 
tive dose of diazepam, reported to give 90% oc- 
cupancy of brain receptors in vivo [7]; this effect 
showed regional specificity since it was observed in 
hippocampus but not cerebellum of treated rats. 
The differences between the two areas cannot be 
ascribed to different levels of diazepam, since we 
found uniform regional drug distribution after in 
vivo treatment and, when added in vitro to crude 
synaptic membrane preparations, diazepam pro- 
duced a dose-dependent effect in hippocampus but 
not in cerebellum. The lack of fluidizing effect in 
diazepam in cerebellum may be due to the presence 
of only one type of BDZ receptor protein [8,9] or 
to different membrane constituents. 
The enhancement of membrane fluidity by 
diazepam does not seem to be related to the 
‘neuronal type’ of benzodiazepine receptors, since 
it was shared in vitro by the potent benzodiazepine 
antagonist Ro 15-1788 and by PK 11195, a specific 
ligand for the peripheral type of receptors [lo]. 
Moreover zopicione, a non-benzodiazepine Iigand 
for the neuronal type of benzodiazepine receptors 
[l I], had no effect on in vitro crude synaptic mem- 
brane preparation. Our data also indicate that the 
enhancement of membrane fluidity by diazepam 
does not correlate with its pharmacological activi- 
ty, since Ro 15-1788, given in vivo at a dose which 
compIetely antagonizes the pharmacological ef- 
fects of diazepam [ 121, per se increased membrane 
fluidity in hippocampal synaptosomes and was not 
able to reverse diazepam’s fluidizing effects. 
Moreover, the enhancement of membrane 
fluidity observed in our conditions does not seem 
to be mediated by the peripheral type of BDZ 
receptors present in the brain, since these sites are 
more concentrated in cerebellum than in hip- 
pocampus [13] and PK 11195, which binds these 
sites with higher affinity than diazepam [lo], was 
considerably less active than the benzodiazepine in 
enhancing membrane fluidity, its effect being com- 
parabIe to that of Ro 15-1788. In any case the con- 
centrations of the tested drugs active in vitro on 
membrane fluidity are higher than their affinity 
constants for nanomolar receptors. A micromolar 
benzodiazepine receptor, which aIso binds pheny- 
toin, has been described [141 and seems to correlate 
with the ability of anticonvulsants to inhibit 
Ca2+-calmodulin kinase activity [ 151, 
Protein phosphorylation activity has been 
reported to be passively modulated by in vitro or 
in vivo changes in membrane fluidity [16]. Studies 
are in progress in our laboratory to check whether 
the increase in fluidity of hippocampal crude 
synaptic membranes is related to the inhibition of 
protein kinase linked to a generalized anticonvul- 
sant receptor, through which the drugs under study 
modulate neuronal excitability. 
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